IP Library › Granted Patent US 9,084,734
Granted Patent B2
US 9,084,734 · App. 11/919,717 · Granted Jul 21, 2015

Peptide personal care compositions and methods for their use

Inventors: Katherine D. Collier (Los Altos, CA); Anthony Day (San Francisco, CA); Hans de Nobel (Heemstede, NL); David A. Estell (San Francisco, CA); Grant C. Ganshaw (Tracy, CA); Marc Kolkman (Oegsteest, NL); Raj Lad (San Mateo, CA); Jeffrey V. Miller (Menlo Park, CA); Christopher J. Murray (Soquel, CA); Scott D. Power (San Bruno, CA); Brian Schmidt (Half Moon Bay, CA); Anita van Kimmenade (San Bruno, CA); Gudrun Vogtentanz (Sunnyvale, CA)
Assignee: Danisco US Inc.
A61K8/64A61K8/66A61Q1/02A61Q1/04A61Q1/10A61Q7/02A61Q9/00A61Q15/00A61Q17/04A61Q19/02A61Q19/04A61Q19/10C07K7/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,084,734
App. No.
11/919,717
Granted
Jul 21, 2015
Kind
B2
Abstract

The present invention provides peptides and supported peptides for treating various diseases and conditions. In particularly preferred embodiments, the present invention provides compositions and methods for personal care. In some embodiments the present invention provides compositions for use in skin and/or hair care, as well as cosmetic compositions. IN alternative particularly preferred embodiments, the present invention provides peptides and supported peptides for treating diseases of the skin, such as rosacea. In some particularly preferred embodiments, the supported peptides of the present invention are anti-VEGF peptides. In alternative particularly preferred embodiments, the anti-VEGF peptides are expressed on a scaffold protein. In some most preferred embodiments, the scaffold protein comprises BBI.

Claims (42)

1. A personal care composition comprising a scaffold, wherein said scaffold comprises a protease inhibitor and at least one peptide selected from the group consisting of SEQ ID NOS:1-17.

2. The personal care composition of claim 1 , wherein said protease inhibitor is selected from the group consisting of Bowman-Birk inhibitor, soybean trypsin inhibitor, and Elgin chymotrypsin inhibitor.

3. The personal care composition of claim 2 , wherein said Bowman-Birk inhibitor is a modified Bowman-Birk inhibitor.

4. The personal care composition of claim 1 , wherein said scaffold comprises from about 0.001 weight percent to about 5 weight percent of said personal care composition.

5. The personal care composition of claim 4 , wherein said scaffold comprises from about 0.01 weight percent to about 2.0 weight percent of said personal care composition.

6. The personal care composition of claim 5 , wherein said scaffold comprises from about 0.01 weight percent to about 1 weight percent of said personal care composition.

7. The composition of claim 1 , wherein said personal care composition is a skin care composition selected from the group consisting of skin creams, lotions, sprays, emulsions, colloidal suspensions, foams, aerosols, liquids, gels, sera, and solids.

8. The composition of claim 7 , wherein said skin care composition comprising topically applied over-the-counter compositions, anti-fungal treatments, anti-acne treatments, skin protectants, sunscreens, deodorants, and antiperspirants.

9. The composition of claim 7 , wherein said composition is:

i) capable of lightening the skin tone;

ii) capable of reducing redness in skin tone;

iii) capable of preventing skin tone darkening;

iv) capable of preventing skin color development; and/or

v) radioprotective.

10. The composition of claim 1 , wherein said personal care composition is capable of preventing hair growth.

11. The composition of claim 1 , wherein said personal care composition is a hair care composition.

12. A personal care composition comprising a scaffold, wherein said scaffold comprises a protease inhibitor and at least one peptide selected from the group consisting of SEQ ID NOS:1-17 and is a cosmetic composition.

13. The composition of claim 12 , wherein said cosmetic composition is a makeup composition selected from eye gels, eye shadows, high-melting point lipsticks, lipsticks, lip glosses, lip balms, mascaras, eyeliners, pressed powder formulations, and foundations.

14. The composition of claim 13 , wherein said makeup composition comprises at least one pigment.

15. The personal care composition of claim 1 , wherein said scaffold comprises the amino acid sequence set forth in SEQ ID NO:19.

16. The personal care composition of claim 1 , wherein said scaffold further comprises at least one amino acid sequence set forth in SEQ ID NOS:20 and 21.

17. The personal care composition of claim 16 , wherein at least one of said amino acid sequences set forth in SEQ ID NOS: 20 and 21 is replaced by at least one peptide having an amino acid sequence selected from the group consisting of SEQ ID NOS:1-17.

18. The personal care composition of claim 1 , wherein said scaffold comprises an amino acid sequence selected from the group consisting of SEQ ID NOS:22-25.

19. A method for making the personal care composition of claim 1 , comprising combining an effective amount of said scaffold and at least one physiologically acceptable carrier or excipient.

20. A method for modifying the skin tone of a subject, comprising the steps of:

i) providing a composition comprising the personal care composition of claim 1 ;

ii) providing a subject to be treated; and

iii) applying said composition to said subject in an area in which modifications to said subject's skin tone is desired.

21. The method of claim 20 , wherein said personal care composition comprises the amino acid sequence set forth in SEQ ID NO:19.

22. The method of claim 20 , wherein said personal care composition comprises at least one amino acid sequence set forth in SEQ ID NOS:20 and 21.

23. The method of claim 20 , wherein at least one of said amino acid sequences set forth in SEQ ID NOS:20 and 21 is replaced by at least one peptide having an amino acid sequence selected from the group consisting of SEQ ID NOS:1-17.

24. The method of claim 20 , wherein said personal care composition is encoded by an amino acid sequence selected from the group consisting of SEQ ID NOS:22-25.

25. A method for modifying the hair growth of a subject, comprising the steps of:

i) providing the personal care composition of claim 1 ;

ii)providing a subject to be treated; and

iii) applying said composition to said subject in an area in which modifications to said subject's hair growth is desired.

26. The method of claim 25 , wherein said modification of hair growth comprises inhibiting the growth of said subject's hair.

27. The method of claim 25 , wherein said modification of hair growth comprises inhibiting the growth of said subject's hair, wherein said hair to be inhibited is selected from the group consisting of facial air, underarm hair, leg hair, torso hair, and arm hair, and head hair.

28. The method of claim 25 , wherein said personal care composition comprises the amino acid sequence set forth in SEQ ID NO:19.

29. The method of claim 25 , wherein said personal care composition comprises at least one amino acid sequence set forth in SEQ ID NOS:20 and 21.

30. The method of claim 29 , wherein at least one of said amino acid sequences set forth in SEQ ID NOS:20 and 21 is replaced by at least one peptide having an amino acid sequence selected from the group consisting of SEQ ID NOS:1-17.

31. The method of claim 22 , wherein said personal care composition is encoded by an amino acid sequence selected from the group consisting of SEQ ID NOS:22-25.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 24, 2011
From: MILLER, JEFFREY V.; MURRAY, CHRISTOPHER J.; COLLIER, KATHERINE D.; ESTELL, DAVID A.; GANSHAW, GRANT C.; LAD, RAJ; SCHMIDT, BRIAN; VAN KIMMENADE, ANITA; VOGTENTANZ, GUDRUN; DAY, ANTHONY; DE NOBEL, HANS; KOLKMAN, MARC; POWER, SCOTT D.
To: DANISCO US INC.
Reel/Frame 027110/0756 →
Continuity (2)
Provisional Application 60678601 · May 5, 2005
Related Publication 20120014885A1 · Jan 19, 2012